Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pattern recognition receptors for double-stranded RNA (dsRNA PRRs) represent a functional class of innate immune sensors that detect double-stranded RNA, a hallmark of viral replication and cellular damage (Kawai & Akira, 2010, Nature Immunology). This group includes endosomal receptors like Toll-like receptor 3 (TLR3) and cytoplasmic sensors such as Retinoic acid-inducible gene I (RIG-I) and Melanoma differentiation-associated protein 5 (MDA5) (UniProt). Upon activation, these receptors initiate signaling pathways through adapter proteins like TRIF or MAVS, leading to the production of Type I interferons and pro-inflammatory cytokines (PubMed: 20404850). These molecules play a critical role in defending against viral infections and are increasingly targeted in cancer immunotherapy to turn cold tumors hot by stimulating the tumor microenvironment. Synthetic dsRNA analogues, such as Poly(I:C) and Rintatolimod, act as agonists for these receptors and are used as vaccine adjuvants or direct anti-tumor agents (NIH/NCI). However, because this target definition encompasses multiple distinct proteins with different localizations and signaling outcomes, it is considered a broad classification rather than a single therapeutic target. Therapeutic challenges include the risk of systemic cytokine storms and the potential for inducing autoimmune reactions due to chronic interferon signaling (StatPearls).
Agonism of innate immune sensors to induce Type I interferon and pro-inflammatory cytokine production.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pattern recognition receptors for double-stranded RNA (dsRNA PRRs) (dsRNA PRRs).